Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Current Addiction Reports|June 28, 2023
Improving Translational Research Outcomes for Opioid Use Disorder TreatmentsJermaine D Jones, Neil B Varshneya, Thomas J Hudzik, et al.
Drug and Alcohol Dependence|January 6, 2023
Amphetamines modulate fentanyl-depressed respiration in a bidirectional mannerHarrison J Elder, Neil B Varshneya, D Matthew Walentiny, et al.
Journal of Addiction Medicine|November 24, 2021
Evidence of Buprenorphine-precipitated Withdrawal in Persons Who Use FentanylNeil B Varshneya, Ashish P Thakrar, J Gregory Hobelmann, et al.
Experimental and Clinical Psychopharmacology|March 10, 2022
Can initial experiences with drugs predict future drug abuse risks?Neil B Varshneya, Kelly E Dunn, Caitlyn J Grubb, et al.
Neuropharmacology|March 25, 2019
Opioid-like antinociceptive and locomotor effects of emerging fentanyl-related substancesNeil B Varshneya, D Matthew Walentiny, Lea T Moisa, et al.
Pharmacology, Biochemistry, and Behavior|November 26, 2022
Structurally diverse fentanyl analogs yield differential locomotor activities in miceNeil B Varshneya, D Matthew Walentiny, David L Stevens, et al.
Pharmacology, Biochemistry, and Behavior|July 24, 2021
Fentanyl-related substances elicit antinociception and hyperlocomotion in mice via opioid receptorsNeil B Varshneya, D Matthew Walentiny, Lea T Moisa, et al.
Biochemical Pharmacology|October 21, 2021
Respiratory depressant effects of fentanyl analogs are opioid receptor-mediatedNeil B Varshneya, Sherif H Hassanien, Melissa C Holt, et al.
Pharmacology, Biochemistry, and Behavior|May 26, 2023
Fentanyl analog structure-activity relationships demonstrate determinants of diverging potencies for antinociception and respiratory depressionNeil B Varshneya, Sherif H Hassanien, Melissa C Holt, et al.
Pageof 2